Search Results - "Hernáez, Tania"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave? by Odriozola, Aitor, San Segundo, David, Cuadrado, Antonio, Hernáez, Tania, Escrich, Víctor, Fortea, José Ignacio, Martínez, Ángela, Puente, Ángela, Lapeña, Berta, del Barrio, María, López-Hoyos, Marcos, Crespo, Javier, Fábrega, Emilio

    Published in Transplantation (01-07-2022)
    “…Since the declaration of a new variant of concern (VOC), Omicron, by the World Health Organization in November 2021, a quick spread has been documented…”
    Get full text
    Journal Article
  2. 2

    Risk of recurrence of hepatocellular carcinoma in patients treated with interferon-free antivirals by Hernáez-Alsina, Tania, Caballol-Oliva, Berta, Díaz-González, Álvaro, Guedes-Leal, Cassia, Reig, María

    Published in Gastroenterología y hepatología (01-10-2019)
    “…Eradication of the hepatitis C virus (HCV) with interferon-free therapies (DAAs) has modified the course of the disease, as the rate of patients with…”
    Get more information
    Journal Article
  3. 3

    Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species by Cucarull, Blanca, Tutusaus, Anna, Hernáez-Alsina, Tania, García de Frutos, Pablo, Reig, María, Colell, Anna, Marí, Montserrat, Morales, Albert

    Published in Antioxidants (24-08-2021)
    “…Sorafenib and regorafenib, multikinase inhibitors (MKIs) used as standard chemotherapeutic agents for hepatocellular carcinoma (HCC), generate reactive oxygen…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances by Cucarull, Blanca, Tutusaus, Anna, Rider, Patricia, Hernáez-Alsina, Tania, Cuño, Carlos, García de Frutos, Pablo, Colell, Anna, Marí, Montserrat, Morales, Albert

    Published in Cancers (26-01-2022)
    “…Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to be a serious medical problem with poor prognosis, without major therapeutic…”
    Get full text
    Journal Article
  6. 6

    Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models by Cucarull, Blanca, Tutusaus, Anna, Subías, Miguel, Stefanovic, Milica, Hernáez-Alsina, Tania, Boix, Loreto, Reig, María, García de Frutos, Pablo, Marí, Montserrat, Colell, Anna, Bruix, Jordi, Morales, Albert

    Published in Cancers (01-02-2020)
    “…The multikinase inhibitor regorafenib, approved as second-line treatment for hepatocellular carcinoma (HCC) after sorafenib failure, may induce mitochondrial…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Risk of recurrence of hepatocellular carcinoma in patients treated with interferon-free antivirals by Hernáez-Alsina, Tania, Caballol-Oliva, Berta, Díaz-González, Álvaro, Guedes-Leal, Cassia, Reig, María

    “…Eradication of the hepatitis C virus with interferon-free therapies (DAAs) has modified the course of the disease, as the rate of patients with compensated…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12